Stocks and Investing Stocks and Investing
Tue, July 31, 2018
Mon, July 30, 2018
Fri, July 27, 2018
Thu, July 26, 2018

Matthew Harrison Maintained (VRTX) at Buy with Increased Target to $211 on, Jul 26th, 2018


Published on 2024-10-26 07:12:30 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $207 to $211 on, Jul 26th, 2018.

Matthew, nor any peers, have made any analyst calls on VRTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30